# Cell Therapy for Coronary Heart Disease

> **NCT00289822** · PHASE2 · TERMINATED · sponsor: **Johann Wolfgang Goethe University Hospital** · enrollment: 75 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** intracoronary infusion of progenitor cells

## Key facts

- **NCT ID:** NCT00289822
- **Lead sponsor:** Johann Wolfgang Goethe University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 75 (—)
- **Last updated:** 2006-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00289822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00289822, "Cell Therapy for Coronary Heart Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00289822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*